Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

114.20p
   
  • Change Today:
    -1.40p
  • 52 Week High: 121.60
  • 52 Week Low: 96.40
  • Currency: UK Pounds
  • Shares Issued: 539.52m
  • Volume: 194,547
  • Market Cap: £616.13m
  • RiskGrade: 119

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 1.5% 1.5%
Div Cover 3.8 3.8
Op Mrgn 13.2% 22.0%
ROCE 46.4%  
Latest F'cast
P/E 18.1 17.2
PEG 0.7 9.1
Pr/Revenue 3.8 3.2
Pr/Book 2.2  
Latest F'cast
Revenue 25.7% 17.1%
PBT 39.5% 131.8%
EPS 25.0% 1.9%
DPS 5.0% 1.4%

Alliance Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 101.64 28.29 5.33p 12.6 0.3 +38% 1.33p 2.0%
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 191.06 42.08 6.51p 17.8 9.4 +2% 1.72p 1.5%
31-Dec-23 208.83 47.52 6.98p 16.6 2.3 +7% 1.81p 1.6%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Block Admission Application 17-Jun-2022 16:00 RNS
Total Voting Rights 08-Jun-2022 07:00 RNS
Notification of Major Holdings 26-May-2022 07:00 RNS

Alliance Pharma ShareCast News

Alliance Pharma in 'good health' amid strong dem... 18-May-2022 ShareCast
Alliance Pharma upbeat on prospects for US acqui... 25-Mar-2022 ShareCast
Alliance Pharma reports 'strong' 2021 performance 22-Mar-2022 ShareCast

Alliance Pharma Top Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 114.20p
Change Today -1.40p
% Change -1.21 %
52 Week High 121.60
52 Week Low 96.40
Volume 194,547
Shares Issued 539.52m
Market Cap £616.13m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.01% below the market average94.01% below the market average94.01% below the market average94.01% below the market average94.01% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Price Trend
86.22% above the market average86.22% above the market average86.22% above the market average86.22% above the market average86.22% above the market average
93.65% above the sector average93.65% above the sector average93.65% above the sector average93.65% above the sector average93.65% above the sector average
Income
70.77% below the market average70.77% below the market average70.77% below the market average70.77% below the market average70.77% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Growth
14.53% above the market average14.53% above the market average14.53% above the market average14.53% above the market average14.53% above the market average
15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average

What The Brokers Say

Strong Buy 5
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 09-Jun-22 16-Dec-21
Paid 07-Jul-22 07-Jan-22
Amount 1.13p 0.56p

Trades for 29-Jun-2022

Time Volume / Share Price
10:09 5 @ 114.09p
10:07 2,792 @ 114.30p
10:06 2,450 @ 113.96p
10:06 2,792 @ 114.30p
10:06 5 @ 114.09p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page